Pre-Endoscopy GLP-1 RAs Don’t Always Cause Gastric Retention
Study recommended triaging by diabetes-related risk before stopping medication preoperatively. Medscape Medical News
‘Clear Advantage’ of GLP-1s for IIH vs Conventional Therapy
Patients with idiopathic intracranial hypertension who use a GLP-1 receptor agonist are less likely to experience symptoms, require medications, or undergo surgery. Medscape Medical News
The Ultimate Gut-Health Grocery List To Boost GLP-1 Naturally
Add these to your grocery cart for a healthier gut & metabolism.
Dementia risk does not differ with GLP-1 RAs, DPP4is for seniors with type 2 diabetes, study finds
For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1 receptor agonists (GLP-1 RAs) versus dipeptidyl peptidase-4 inhibitors (DPP4is), according to a study published online in the Annals of Internal Medicine.
Study of GLP-1 guidelines for teens points to potential for influence from drugmakers
American Academy of Pediatrics guidelines that set off a new era in obesity treatment — and a national debate about whether children should be prescribed weight loss drugs — may have been shaped by pharmaceutical industry influence, a new analysis suggests. Over one-third of people who helped develop the 2023 “Clinical Practice Guideline for the […]
How food brands can stay ahead of GLP-1 craze
Discover how food brands can adapt to the rising GLP-1 trend. As weight-loss drugs reshape consumer habits, learn which categories are most at risk, where new opportunities lie, and how to innovate for appetite-conscious consumers.
GLP-1 drugs fail to provide a key benefit of substantial weight loss
Weight-loss drugs like semaglutide and tirzepatide may help shrink waistlines, but new research shows they fail to boost fitness and can cause serious muscle loss, potentially undermining the long-term health benefits of slimming down. Continue Reading Category: Wellness & Healthy Living, Body & Mind Tags: GLP-1 receptor agonists, Weight Loss, Muscle, Fitness, Cardiovascular, University of […]
Role of GLP-1 Drugs in Psoriasis and PsA Is Debated
While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge caution. Medscape Medical News
Incretin Receptors in the Peripheral Nervous System: Implications for Obesity Treatment and Peripheral Neuropathy
There is currently a revolution in the pharmacologic treatment of obesity and diabetes with newly available agonists of incretin receptors. The health benefits of these novel treatments include not only metabolic effects but also improvements in brain neurodegenerative conditions. Receptors for incretins have been described in the hypothalamic appetite regulatory center; however, their expression in […]
Combined amylin analogue and GLP1 receptor agonist therapies are highly promising for weight loss
Nature Reviews Endocrinology, Published online: 21 July 2025; doi:10.1038/s41574-025-01156-2 Combined amylin analogue and GLP1 receptor agonist therapies are highly promising for weight loss